Global Biosimilar Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 91

Published Date: 18 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilar drug is officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

According to our (Global Info Research) latest study, the global Biosimilar Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

In China, Biosimilar Drug key players include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, etc. Global top three manufacturers hold a share over 70%.

East China is the largest market, with a share over 70%, followed by North China, with a share about 15 percent.

In terms of product, Tablets is the largest segment, with a share over 65%. And in terms of application, the largest application is Ankylosing Spondylitis, followed by Rheumatoid Arthrtis, Tumor, Cardiovascular, etc.

This report is a detailed and comprehensive analysis for global Biosimilar Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Biosimilar Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2018-2029
Global Biosimilar Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2018-2029
Global Biosimilar Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (USD/Dose), 2018-2029
Global Biosimilar Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (USD/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biosimilar Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biosimilar Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CP Guojian Pharma, Biotech Pharma, Celgen Pharma, Henlius and Amgen, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Biosimilar Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Injection
    Tablets
    Other Types

Market segment by Application
    Ankylosing Spondylitis
    Tumor
    Rheumatoid Arthrtis
    Cardiovascular
    Other Application

Major players covered
    CP Guojian Pharma
    Biotech Pharma
    Celgen Pharma
    Henlius
    Amgen
    Eli Lilly
    Sandoz
    Changchun High Tech
    Innovent

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilar Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biosimilar Drug, with price, sales, revenue and global market share of Biosimilar Drug from 2018 to 2023.
Chapter 3, the Biosimilar Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilar Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biosimilar Drug.
Chapter 14 and 15, to describe Biosimilar Drug sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Biosimilar Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Biosimilar Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Injection
        1.3.3 Tablets
        1.3.4 Other Types
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Biosimilar Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Ankylosing Spondylitis
        1.4.3 Tumor
        1.4.4 Rheumatoid Arthrtis
        1.4.5 Cardiovascular
        1.4.6 Other Application
    1.5 Global Biosimilar Drug Market Size & Forecast
        1.5.1 Global Biosimilar Drug Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Biosimilar Drug Sales Quantity (2018-2029)
        1.5.3 Global Biosimilar Drug Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 CP Guojian Pharma
        2.1.1 CP Guojian Pharma Details
        2.1.2 CP Guojian Pharma Major Business
        2.1.3 CP Guojian Pharma Biosimilar Drug Product and Services
        2.1.4 CP Guojian Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 CP Guojian Pharma Recent Developments/Updates
    2.2 Biotech Pharma
        2.2.1 Biotech Pharma Details
        2.2.2 Biotech Pharma Major Business
        2.2.3 Biotech Pharma Biosimilar Drug Product and Services
        2.2.4 Biotech Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Biotech Pharma Recent Developments/Updates
    2.3 Celgen Pharma
        2.3.1 Celgen Pharma Details
        2.3.2 Celgen Pharma Major Business
        2.3.3 Celgen Pharma Biosimilar Drug Product and Services
        2.3.4 Celgen Pharma Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Celgen Pharma Recent Developments/Updates
    2.4 Henlius
        2.4.1 Henlius Details
        2.4.2 Henlius Major Business
        2.4.3 Henlius Biosimilar Drug Product and Services
        2.4.4 Henlius Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Henlius Recent Developments/Updates
    2.5 Amgen
        2.5.1 Amgen Details
        2.5.2 Amgen Major Business
        2.5.3 Amgen Biosimilar Drug Product and Services
        2.5.4 Amgen Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Amgen Recent Developments/Updates
    2.6 Eli Lilly
        2.6.1 Eli Lilly Details
        2.6.2 Eli Lilly Major Business
        2.6.3 Eli Lilly Biosimilar Drug Product and Services
        2.6.4 Eli Lilly Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Eli Lilly Recent Developments/Updates
    2.7 Sandoz
        2.7.1 Sandoz Details
        2.7.2 Sandoz Major Business
        2.7.3 Sandoz Biosimilar Drug Product and Services
        2.7.4 Sandoz Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Sandoz Recent Developments/Updates
    2.8 Changchun High Tech
        2.8.1 Changchun High Tech Details
        2.8.2 Changchun High Tech Major Business
        2.8.3 Changchun High Tech Biosimilar Drug Product and Services
        2.8.4 Changchun High Tech Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Changchun High Tech Recent Developments/Updates
    2.9 Innovent
        2.9.1 Innovent Details
        2.9.2 Innovent Major Business
        2.9.3 Innovent Biosimilar Drug Product and Services
        2.9.4 Innovent Biosimilar Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Innovent Recent Developments/Updates

3 Competitive Environment: Biosimilar Drug by Manufacturer
    3.1 Global Biosimilar Drug Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Biosimilar Drug Revenue by Manufacturer (2018-2023)
    3.3 Global Biosimilar Drug Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Biosimilar Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Biosimilar Drug Manufacturer Market Share in 2022
        3.4.2 Top 6 Biosimilar Drug Manufacturer Market Share in 2022
    3.5 Biosimilar Drug Market: Overall Company Footprint Analysis
        3.5.1 Biosimilar Drug Market: Region Footprint
        3.5.2 Biosimilar Drug Market: Company Product Type Footprint
        3.5.3 Biosimilar Drug Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Biosimilar Drug Market Size by Region
        4.1.1 Global Biosimilar Drug Sales Quantity by Region (2018-2029)
        4.1.2 Global Biosimilar Drug Consumption Value by Region (2018-2029)
        4.1.3 Global Biosimilar Drug Average Price by Region (2018-2029)
    4.2 North America Biosimilar Drug Consumption Value (2018-2029)
    4.3 Europe Biosimilar Drug Consumption Value (2018-2029)
    4.4 Asia-Pacific Biosimilar Drug Consumption Value (2018-2029)
    4.5 South America Biosimilar Drug Consumption Value (2018-2029)
    4.6 Middle East and Africa Biosimilar Drug Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Biosimilar Drug Sales Quantity by Type (2018-2029)
    5.2 Global Biosimilar Drug Consumption Value by Type (2018-2029)
    5.3 Global Biosimilar Drug Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Biosimilar Drug Sales Quantity by Application (2018-2029)
    6.2 Global Biosimilar Drug Consumption Value by Application (2018-2029)
    6.3 Global Biosimilar Drug Average Price by Application (2018-2029)

7 North America
    7.1 North America Biosimilar Drug Sales Quantity by Type (2018-2029)
    7.2 North America Biosimilar Drug Sales Quantity by Application (2018-2029)
    7.3 North America Biosimilar Drug Market Size by Country
        7.3.1 North America Biosimilar Drug Sales Quantity by Country (2018-2029)
        7.3.2 North America Biosimilar Drug Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Biosimilar Drug Sales Quantity by Type (2018-2029)
    8.2 Europe Biosimilar Drug Sales Quantity by Application (2018-2029)
    8.3 Europe Biosimilar Drug Market Size by Country
        8.3.1 Europe Biosimilar Drug Sales Quantity by Country (2018-2029)
        8.3.2 Europe Biosimilar Drug Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Biosimilar Drug Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Biosimilar Drug Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Biosimilar Drug Market Size by Region
        9.3.1 Asia-Pacific Biosimilar Drug Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Biosimilar Drug Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Biosimilar Drug Sales Quantity by Type (2018-2029)
    10.2 South America Biosimilar Drug Sales Quantity by Application (2018-2029)
    10.3 South America Biosimilar Drug Market Size by Country
        10.3.1 South America Biosimilar Drug Sales Quantity by Country (2018-2029)
        10.3.2 South America Biosimilar Drug Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Biosimilar Drug Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Biosimilar Drug Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Biosimilar Drug Market Size by Country
        11.3.1 Middle East & Africa Biosimilar Drug Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Biosimilar Drug Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Biosimilar Drug Market Drivers
    12.2 Biosimilar Drug Market Restraints
    12.3 Biosimilar Drug Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Biosimilar Drug and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Biosimilar Drug
    13.3 Biosimilar Drug Production Process
    13.4 Biosimilar Drug Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Biosimilar Drug Typical Distributors
    14.3 Biosimilar Drug Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Biosimilar Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Biosimilar Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. CP Guojian Pharma Basic Information, Manufacturing Base and Competitors
    Table 4. CP Guojian Pharma Major Business
    Table 5. CP Guojian Pharma Biosimilar Drug Product and Services
    Table 6. CP Guojian Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. CP Guojian Pharma Recent Developments/Updates
    Table 8. Biotech Pharma Basic Information, Manufacturing Base and Competitors
    Table 9. Biotech Pharma Major Business
    Table 10. Biotech Pharma Biosimilar Drug Product and Services
    Table 11. Biotech Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Biotech Pharma Recent Developments/Updates
    Table 13. Celgen Pharma Basic Information, Manufacturing Base and Competitors
    Table 14. Celgen Pharma Major Business
    Table 15. Celgen Pharma Biosimilar Drug Product and Services
    Table 16. Celgen Pharma Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Celgen Pharma Recent Developments/Updates
    Table 18. Henlius Basic Information, Manufacturing Base and Competitors
    Table 19. Henlius Major Business
    Table 20. Henlius Biosimilar Drug Product and Services
    Table 21. Henlius Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Henlius Recent Developments/Updates
    Table 23. Amgen Basic Information, Manufacturing Base and Competitors
    Table 24. Amgen Major Business
    Table 25. Amgen Biosimilar Drug Product and Services
    Table 26. Amgen Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Amgen Recent Developments/Updates
    Table 28. Eli Lilly Basic Information, Manufacturing Base and Competitors
    Table 29. Eli Lilly Major Business
    Table 30. Eli Lilly Biosimilar Drug Product and Services
    Table 31. Eli Lilly Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Eli Lilly Recent Developments/Updates
    Table 33. Sandoz Basic Information, Manufacturing Base and Competitors
    Table 34. Sandoz Major Business
    Table 35. Sandoz Biosimilar Drug Product and Services
    Table 36. Sandoz Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Sandoz Recent Developments/Updates
    Table 38. Changchun High Tech Basic Information, Manufacturing Base and Competitors
    Table 39. Changchun High Tech Major Business
    Table 40. Changchun High Tech Biosimilar Drug Product and Services
    Table 41. Changchun High Tech Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Changchun High Tech Recent Developments/Updates
    Table 43. Innovent Basic Information, Manufacturing Base and Competitors
    Table 44. Innovent Major Business
    Table 45. Innovent Biosimilar Drug Product and Services
    Table 46. Innovent Biosimilar Drug Sales Quantity (K Dose), Average Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Innovent Recent Developments/Updates
    Table 48. Global Biosimilar Drug Sales Quantity by Manufacturer (2018-2023) & (K Dose)
    Table 49. Global Biosimilar Drug Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 50. Global Biosimilar Drug Average Price by Manufacturer (2018-2023) & (USD/Dose)
    Table 51. Market Position of Manufacturers in Biosimilar Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 52. Head Office and Biosimilar Drug Production Site of Key Manufacturer
    Table 53. Biosimilar Drug Market: Company Product Type Footprint
    Table 54. Biosimilar Drug Market: Company Product Application Footprint
    Table 55. Biosimilar Drug New Market Entrants and Barriers to Market Entry
    Table 56. Biosimilar Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 57. Global Biosimilar Drug Sales Quantity by Region (2018-2023) & (K Dose)
    Table 58. Global Biosimilar Drug Sales Quantity by Region (2024-2029) & (K Dose)
    Table 59. Global Biosimilar Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 60. Global Biosimilar Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 61. Global Biosimilar Drug Average Price by Region (2018-2023) & (USD/Dose)
    Table 62. Global Biosimilar Drug Average Price by Region (2024-2029) & (USD/Dose)
    Table 63. Global Biosimilar Drug Sales Quantity by Type (2018-2023) & (K Dose)
    Table 64. Global Biosimilar Drug Sales Quantity by Type (2024-2029) & (K Dose)
    Table 65. Global Biosimilar Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 66. Global Biosimilar Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 67. Global Biosimilar Drug Average Price by Type (2018-2023) & (USD/Dose)
    Table 68. Global Biosimilar Drug Average Price by Type (2024-2029) & (USD/Dose)
    Table 69. Global Biosimilar Drug Sales Quantity by Application (2018-2023) & (K Dose)
    Table 70. Global Biosimilar Drug Sales Quantity by Application (2024-2029) & (K Dose)
    Table 71. Global Biosimilar Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. Global Biosimilar Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. Global Biosimilar Drug Average Price by Application (2018-2023) & (USD/Dose)
    Table 74. Global Biosimilar Drug Average Price by Application (2024-2029) & (USD/Dose)
    Table 75. North America Biosimilar Drug Sales Quantity by Type (2018-2023) & (K Dose)
    Table 76. North America Biosimilar Drug Sales Quantity by Type (2024-2029) & (K Dose)
    Table 77. North America Biosimilar Drug Sales Quantity by Application (2018-2023) & (K Dose)
    Table 78. North America Biosimilar Drug Sales Quantity by Application (2024-2029) & (K Dose)
    Table 79. North America Biosimilar Drug Sales Quantity by Country (2018-2023) & (K Dose)
    Table 80. North America Biosimilar Drug Sales Quantity by Country (2024-2029) & (K Dose)
    Table 81. North America Biosimilar Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 82. North America Biosimilar Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 83. Europe Biosimilar Drug Sales Quantity by Type (2018-2023) & (K Dose)
    Table 84. Europe Biosimilar Drug Sales Quantity by Type (2024-2029) & (K Dose)
    Table 85. Europe Biosimilar Drug Sales Quantity by Application (2018-2023) & (K Dose)
    Table 86. Europe Biosimilar Drug Sales Quantity by Application (2024-2029) & (K Dose)
    Table 87. Europe Biosimilar Drug Sales Quantity by Country (2018-2023) & (K Dose)
    Table 88. Europe Biosimilar Drug Sales Quantity by Country (2024-2029) & (K Dose)
    Table 89. Europe Biosimilar Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 90. Europe Biosimilar Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 91. Asia-Pacific Biosimilar Drug Sales Quantity by Type (2018-2023) & (K Dose)
    Table 92. Asia-Pacific Biosimilar Drug Sales Quantity by Type (2024-2029) & (K Dose)
    Table 93. Asia-Pacific Biosimilar Drug Sales Quantity by Application (2018-2023) & (K Dose)
    Table 94. Asia-Pacific Biosimilar Drug Sales Quantity by Application (2024-2029) & (K Dose)
    Table 95. Asia-Pacific Biosimilar Drug Sales Quantity by Region (2018-2023) & (K Dose)
    Table 96. Asia-Pacific Biosimilar Drug Sales Quantity by Region (2024-2029) & (K Dose)
    Table 97. Asia-Pacific Biosimilar Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 98. Asia-Pacific Biosimilar Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 99. South America Biosimilar Drug Sales Quantity by Type (2018-2023) & (K Dose)
    Table 100. South America Biosimilar Drug Sales Quantity by Type (2024-2029) & (K Dose)
    Table 101. South America Biosimilar Drug Sales Quantity by Application (2018-2023) & (K Dose)
    Table 102. South America Biosimilar Drug Sales Quantity by Application (2024-2029) & (K Dose)
    Table 103. South America Biosimilar Drug Sales Quantity by Country (2018-2023) & (K Dose)
    Table 104. South America Biosimilar Drug Sales Quantity by Country (2024-2029) & (K Dose)
    Table 105. South America Biosimilar Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 106. South America Biosimilar Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 107. Middle East & Africa Biosimilar Drug Sales Quantity by Type (2018-2023) & (K Dose)
    Table 108. Middle East & Africa Biosimilar Drug Sales Quantity by Type (2024-2029) & (K Dose)
    Table 109. Middle East & Africa Biosimilar Drug Sales Quantity by Application (2018-2023) & (K Dose)
    Table 110. Middle East & Africa Biosimilar Drug Sales Quantity by Application (2024-2029) & (K Dose)
    Table 111. Middle East & Africa Biosimilar Drug Sales Quantity by Region (2018-2023) & (K Dose)
    Table 112. Middle East & Africa Biosimilar Drug Sales Quantity by Region (2024-2029) & (K Dose)
    Table 113. Middle East & Africa Biosimilar Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 114. Middle East & Africa Biosimilar Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 115. Biosimilar Drug Raw Material
    Table 116. Key Manufacturers of Biosimilar Drug Raw Materials
    Table 117. Biosimilar Drug Typical Distributors
    Table 118. Biosimilar Drug Typical Customers
List of Figures
    Figure 1. Biosimilar Drug Picture
    Figure 2. Global Biosimilar Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Biosimilar Drug Consumption Value Market Share by Type in 2022
    Figure 4. Injection Examples
    Figure 5. Tablets Examples
    Figure 6. Other Types Examples
    Figure 7. Global Biosimilar Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Biosimilar Drug Consumption Value Market Share by Application in 2022
    Figure 9. Ankylosing Spondylitis Examples
    Figure 10. Tumor Examples
    Figure 11. Rheumatoid Arthrtis Examples
    Figure 12. Cardiovascular Examples
    Figure 13. Other Application Examples
    Figure 14. Global Biosimilar Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Biosimilar Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Biosimilar Drug Sales Quantity (2018-2029) & (K Dose)
    Figure 17. Global Biosimilar Drug Average Price (2018-2029) & (USD/Dose)
    Figure 18. Global Biosimilar Drug Sales Quantity Market Share by Manufacturer in 2022
    Figure 19. Global Biosimilar Drug Consumption Value Market Share by Manufacturer in 2022
    Figure 20. Producer Shipments of Biosimilar Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 21. Top 3 Biosimilar Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Top 6 Biosimilar Drug Manufacturer (Consumption Value) Market Share in 2022
    Figure 23. Global Biosimilar Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 24. Global Biosimilar Drug Consumption Value Market Share by Region (2018-2029)
    Figure 25. North America Biosimilar Drug Consumption Value (2018-2029) & (USD Million)
    Figure 26. Europe Biosimilar Drug Consumption Value (2018-2029) & (USD Million)
    Figure 27. Asia-Pacific Biosimilar Drug Consumption Value (2018-2029) & (USD Million)
    Figure 28. South America Biosimilar Drug Consumption Value (2018-2029) & (USD Million)
    Figure 29. Middle East & Africa Biosimilar Drug Consumption Value (2018-2029) & (USD Million)
    Figure 30. Global Biosimilar Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 31. Global Biosimilar Drug Consumption Value Market Share by Type (2018-2029)
    Figure 32. Global Biosimilar Drug Average Price by Type (2018-2029) & (USD/Dose)
    Figure 33. Global Biosimilar Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 34. Global Biosimilar Drug Consumption Value Market Share by Application (2018-2029)
    Figure 35. Global Biosimilar Drug Average Price by Application (2018-2029) & (USD/Dose)
    Figure 36. North America Biosimilar Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 37. North America Biosimilar Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 38. North America Biosimilar Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 39. North America Biosimilar Drug Consumption Value Market Share by Country (2018-2029)
    Figure 40. United States Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Canada Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Mexico Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 43. Europe Biosimilar Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 44. Europe Biosimilar Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 45. Europe Biosimilar Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 46. Europe Biosimilar Drug Consumption Value Market Share by Country (2018-2029)
    Figure 47. Germany Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. France Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. United Kingdom Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Russia Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Italy Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 53. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 54. Asia-Pacific Biosimilar Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 55. Asia-Pacific Biosimilar Drug Consumption Value Market Share by Region (2018-2029)
    Figure 56. China Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Japan Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Korea Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. India Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Southeast Asia Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Australia Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. South America Biosimilar Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 63. South America Biosimilar Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 64. South America Biosimilar Drug Sales Quantity Market Share by Country (2018-2029)
    Figure 65. South America Biosimilar Drug Consumption Value Market Share by Country (2018-2029)
    Figure 66. Brazil Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Argentina Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 68. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Type (2018-2029)
    Figure 69. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Application (2018-2029)
    Figure 70. Middle East & Africa Biosimilar Drug Sales Quantity Market Share by Region (2018-2029)
    Figure 71. Middle East & Africa Biosimilar Drug Consumption Value Market Share by Region (2018-2029)
    Figure 72. Turkey Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Egypt Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Saudi Arabia Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. South Africa Biosimilar Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. Biosimilar Drug Market Drivers
    Figure 77. Biosimilar Drug Market Restraints
    Figure 78. Biosimilar Drug Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Biosimilar Drug in 2022
    Figure 81. Manufacturing Process Analysis of Biosimilar Drug
    Figure 82. Biosimilar Drug Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Biosimilar Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Biosimilar Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Biosimilar Drug market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global Biosimilar Drug Supply, Demand and Key Producers, 2024-2030

Global Biosimilar Drug Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Pharma & Healthcare

The global Biosimilar Drug market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>